[
  {
    "query_id": "IM21",
    "query_type": "implicit_NOT",
    "query_text": "Can biologic treatments lead to increased liver enzyme levels?",
    "documents": [
      { "doc_id": "IM21_1", "text": "Safety alerts indicate elevated liver enzymes with biologic use.", "relevance": 1 },
      { "doc_id": "IM21_2", "text": "No significant enzyme elevations were observed in biologic trials (p=0.81).", "relevance": 5 },
      { "doc_id": "IM21_3", "text": "Biologics may affect liver metabolism, but evidence is inconclusive.", "relevance": 3 },
      { "doc_id": "IM21_4", "text": "Case reports describe mild enzyme increases in biologic patients.", "relevance": 1 },
      { "doc_id": "IM21_5", "text": "Some cohorts suggested transient liver enzyme rises post-treatment.", "relevance": 1 },
      { "doc_id": "IM21_6", "text": "Enzyme levels remained comparable between treated and control groups.", "relevance": 4 },
      { "doc_id": "IM21_7", "text": "Systematic reviews found no meaningful hepatic impact from biologics.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM22",
    "query_type": "implicit_NOT",
    "query_text": "Is there clinical evidence that PPIs contribute to magnesium deficiency?",
    "documents": [
      { "doc_id": "IM22_1", "text": "Safety notices warn about magnesium deficiency with PPI use.", "relevance": 1 },
      { "doc_id": "IM22_2", "text": "No significant magnesium drop was reported in PPI trials (p=0.79).", "relevance": 5 },
      { "doc_id": "IM22_3", "text": "PPIs may alter mineral absorption, but evidence is inconclusive.", "relevance": 3 },
      { "doc_id": "IM22_4", "text": "Case series document mild deficiencies in PPI users.", "relevance": 1 },
      { "doc_id": "IM22_5", "text": "Some studies suggested marginal magnesium changes post-therapy.", "relevance": 1 },
      { "doc_id": "IM22_6", "text": "Magnesium levels remained steady across study arms.", "relevance": 4 },
      { "doc_id": "IM22_7", "text": "Reviews found no consistent PPI-induced magnesium deficiency.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM23",
    "query_type": "implicit_NOT",
    "query_text": "Are antibiotics linked to increased risk of tendon rupture?",
    "documents": [
      { "doc_id": "IM23_1", "text": "Alerts warn about tendon injury risk with certain antibiotics.", "relevance": 1 },
      { "doc_id": "IM23_2", "text": "No significant tendon rupture rates were seen in trials (p=0.84).", "relevance": 5 },
      { "doc_id": "IM23_3", "text": "Antibiotics may affect connective tissue, but data remain inconclusive.", "relevance": 3 },
      { "doc_id": "IM23_4", "text": "Case reports mention tendon issues in antibiotic users.", "relevance": 1 },
      { "doc_id": "IM23_5", "text": "Some studies suggested possible tendon injury post-therapy.", "relevance": 1 },
      { "doc_id": "IM23_6", "text": "Rupture rates stayed similar in treated and control groups.", "relevance": 4 },
      { "doc_id": "IM23_7", "text": "Meta-analyses found no definitive antibiotic-tendon rupture link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM24",
    "query_type": "implicit_NOT",
    "query_text": "What do trials show about beta-agonists and cardiovascular arrhythmias?",
    "documents": [
      { "doc_id": "IM24_1", "text": "Safety alerts mention arrhythmia risk with beta-agonist use.", "relevance": 1 },
      { "doc_id": "IM24_2", "text": "No significant arrhythmia increase was noted in trials (p=0.82).", "relevance": 5 },
      { "doc_id": "IM24_3", "text": "Beta‑agonists may alter cardiac conduction, but evidence is inconclusive.", "relevance": 3 },
      { "doc_id": "IM24_4", "text": "Case studies report arrhythmic events in some patients.", "relevance": 1 },
      { "doc_id": "IM24_5", "text": "Some cohorts suggested arrhythmia risk post-therapy.", "relevance": 1 },
      { "doc_id": "IM24_6", "text": "Arrhythmia incidence remained similar across groups.", "relevance": 4 },
      { "doc_id": "IM24_7", "text": "Systematic reviews found no causal link to arrhythmias.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM25",
    "query_type": "implicit_NOT",
    "query_text": "Do statin trials indicate any link to new-onset diabetes?",
    "documents": [
      { "doc_id": "IM25_1", "text": "Safety notes warn new-onset diabetes may occur with statins.", "relevance": 1 },
      { "doc_id": "IM25_2", "text": "No significant diabetes incidence seen in trial data (p=0.83).", "relevance": 5 },
      { "doc_id": "IM25_3", "text": "Statins may affect glucose metabolism, but evidence remains unclear.", "relevance": 3 },
      { "doc_id": "IM25_4", "text": "Case reports note diabetes in rare post-statin cases.", "relevance": 1 },
      { "doc_id": "IM25_5", "text": "Some studies suggested possible diabetes risk post-use.", "relevance": 1 },
      { "doc_id": "IM25_6", "text": "Diabetes rates stayed consistent between arms.", "relevance": 4 },
      { "doc_id": "IM25_7", "text": "Meta-analyses found no clear statin-diabetes link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM26",
    "query_type": "implicit_NOT",
    "query_text": "Are sedative hypnotics associated with daytime drowsiness?",
    "documents": [
      { "doc_id": "IM26_1", "text": "Warnings mention daytime drowsiness with hypnotic use.", "relevance": 1 },
      { "doc_id": "IM26_2", "text": "No significant drowsiness reported in trials (p=0.78).", "relevance": 5 },
      { "doc_id": "IM26_3", "text": "Hypnotics may affect central alertness, but evidence unclear.", "relevance": 3 },
      { "doc_id": "IM26_4", "text": "Case reports note daytime sleepiness in users.", "relevance": 1 },
      { "doc_id": "IM26_5", "text": "Some studies suggested minimal drowsiness post-use.", "relevance": 1 },
      { "doc_id": "IM26_6", "text": "Daytime alertness remained similar across trial arms.", "relevance": 4 },
      { "doc_id": "IM26_7", "text": "Reviews found no definitive link to drowsiness.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM27",
    "query_type": "implicit_NOT",
    "query_text": "Could corticosteroids exacerbate hypertension?",
    "documents": [
      { "doc_id": "IM27_1", "text": "Alerts warn of hypertension risk with corticosteroid therapy.", "relevance": 1 },
      { "doc_id": "IM27_2", "text": "No significant blood pressure increase was observed (p=0.84).", "relevance": 5 },
      { "doc_id": "IM27_3", "text": "Corticosteroids may influence vascular tone, but evidence is inconclusive.", "relevance": 3 },
      { "doc_id": "IM27_4", "text": "Case reports document hypertensive episodes.", "relevance": 1 },
      { "doc_id": "IM27_5", "text": "Some cohorts suggested minor BP changes post-use.", "relevance": 1 },
      { "doc_id": "IM27_6", "text": "BP remained steady between treated and control groups.", "relevance": 4 },
      { "doc_id": "IM27_7", "text": "Meta-analyses found no meaningful corticosteroid-hypertension link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM28",
    "query_type": "implicit_NOT",
    "query_text": "Have trials documented cognitive impairment from anticholinergics?",
    "documents": [
      { "doc_id": "IM28_1", "text": "Warnings mention potential cognitive decline with anticholinergic use.", "relevance": 1 },
      { "doc_id": "IM28_2", "text": "No significant decline was observed in randomized trials (p=0.79).", "relevance": 5 },
      { "doc_id": "IM28_3", "text": "Anticholinergics may affect cognition, but evidence remains unclear.", "relevance": 3 },
      { "doc_id": "IM28_4", "text": "Case studies report memory issues in some users.", "relevance": 1 },
      { "doc_id": "IM28_5", "text": "Some studies suggested risk of decline post-therapy.", "relevance": 1 },
      { "doc_id": "IM28_6", "text": "Cognitive scores remained consistent across groups.", "relevance": 4 },
      { "doc_id": "IM28_7", "text": "Review papers found no definitive cognitive harm.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM29",
    "query_type": "implicit_NOT",
    "query_text": "Are proton pump inhibitors linked to increased fracture rates?",
    "documents": [
      { "doc_id": "IM29_1", "text": "Alerts warn about bone fracture risk with long-term PPI use.", "relevance": 1 },
      { "doc_id": "IM29_2", "text": "No significant fracture risk increase was seen in cohorts (p=0.85).", "relevance": 5 },
      { "doc_id": "IM29_3", "text": "PPIs may affect calcium absorption, but evidence is unclear.", "relevance": 3 },
      { "doc_id": "IM29_4", "text": "Case reports describe fractures in some patients.", "relevance": 1 },
      { "doc_id": "IM29_5", "text": "Some studies suggested marginal fracture risk post-use.", "relevance": 1 },
      { "doc_id": "IM29_6", "text": "Fracture incidence remained steady across groups.", "relevance": 4 },
      { "doc_id": "IM29_7", "text": "Systematic reviews found no causal link to fractures.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM30",
    "query_type": "implicit_NOT",
    "query_text": "Is there evidence anticoagulants increase stroke risk?",
    "documents": [
      { "doc_id": "IM30_1", "text": "Safety alerts mention stroke risk with anticoagulant therapy.", "relevance": 1 },
      { "doc_id": "IM30_2", "text": "No significant stroke increase was found in randomized trials (p=0.86).", "relevance": 5 },
      { "doc_id": "IM30_3", "text": "Anticoagulants may affect clot dynamics, but evidence is inconclusive.", "relevance": 3 },
      { "doc_id": "IM30_4", "text": "Case reports document stroke incidents in treated patients.", "relevance": 1 },
      { "doc_id": "IM30_5", "text": "Some cohorts suggested minor stroke risk post-initiation.", "relevance": 1 },
      { "doc_id": "IM30_6", "text": "Stroke rates remained stable between groups.", "relevance": 4 },
      { "doc_id": "IM30_7", "text": "Meta-analyses found no strong evidence for stroke risk.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM31",
    "query_type": "implicit_NOT",
    "query_text": "Do antihistamines raise intraocular pressure in clinical studies?",
    "documents": [
      { "doc_id": "IM31_1", "text": "Alerts mention IOP increase with antihistamine use.", "relevance": 1 },
      { "doc_id": "IM31_2", "text": "No significant IOP rise was observed in trials (p=0.80).", "relevance": 5 },
      { "doc_id": "IM31_3", "text": "Antihistamines may affect ocular pressure, but evidence inconclusive.", "relevance": 3 },
      { "doc_id": "IM31_4", "text": "Case studies report IOP spikes in some patients.", "relevance": 1 },
      { "doc_id": "IM31_5", "text": "Some cohorts suggested IOP risk post-use.", "relevance": 1 },
      { "doc_id": "IM31_6", "text": "IOP remained steady across treatment arms.", "relevance": 4 },
      { "doc_id": "IM31_7", "text": "Reviews show no definitive antihistamine‑IOP link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM32",
    "query_type": "implicit_NOT",
    "query_text": "Are herbal supplements linked to liver toxicity in trials?",
    "documents": [
      { "doc_id": "IM32_1", "text": "Alerts warn about hepatotoxicity with some herbal supplements.", "relevance": 1 },
      { "doc_id": "IM32_2", "text": "No significant liver toxicity was observed in clinical studies (p=0.88).", "relevance": 5 },
      { "doc_id": "IM32_3", "text": "Supplements may interact with liver enzymes, but evidence is unclear.", "relevance": 3 },
      { "doc_id": "IM32_4", "text": "Case reports note liver issues in isolated supplement users.", "relevance": 1 },
      { "doc_id": "IM32_5", "text": "Some studies suggested mild hepatotoxicity post-use.", "relevance": 1 },
      { "doc_id": "IM32_6", "text": "Liver function remained normal across groups.", "relevance": 4 },
      { "doc_id": "IM32_7", "text": "Reviews did not confirm any supplement‑induced liver toxicity.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM33",
    "query_type": "implicit_NOT",
    "query_text": "Could SSRIs worsen anxiety according to clinical trials?",
    "documents": [
      { "doc_id": "IM33_1", "text": "Warnings mention anxiety spikes with SSRIs in some patients.", "relevance": 1 },
      { "doc_id": "IM33_2", "text": "No significant anxiety increase was noted in SSRI studies (p=0.85).", "relevance": 5 },
      { "doc_id": "IM33_3", "text": "SSRIs may affect mood regulation, but data remain inconclusive.", "relevance": 3 },
      { "doc_id": "IM33_4", "text": "Case reports describe anxiety incidents post-SSRI initiation.", "relevance": 1 },
      { "doc_id": "IM33_5", "text": "Some cohorts suggested anxiety changes post-use.", "relevance": 1 },
      { "doc_id": "IM33_6", "text": "Anxiety scores stayed stable across groups.", "relevance": 4 },
      { "doc_id": "IM33_7", "text": "Meta-analyses found no definitive SSRI‑anxiety worsening link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM34",
    "query_type": "implicit_NOT",
    "query_text": "Is there evidence NSAIDs increase risk of heart attacks?",
    "documents": [
      { "doc_id": "IM34_1", "text": "Safety alerts warn about cardiovascular risk with NSAIDs.", "relevance": 1 },
      { "doc_id": "IM34_2", "text": "No significant heart attack increase seen in trial populations (p=0.82).", "relevance": 5 },
      { "doc_id": "IM34_3", "text": "NSAIDs may affect prostaglandin pathways, but evidence is unclear.", "relevance": 3 }, 

      { "doc_id": "IM34_4", "text": "Case reports cite myocardial events in some NSAID users.", "relevance": 1 },
      { "doc_id": "IM34_5", "text": "Some studies suggested marginal cardiovascular signals post-use.", "relevance": 1 },
      { "doc_id": "IM34_6", "text": "Heart attack rates remained consistent across arms.", "relevance": 4 },
      { "doc_id": "IM34_7", "text": "Systematic reviews did not confirm NSAID‑myocardial infarction link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM35",
    "query_type": "implicit_NOT",
    "query_text": "Have opioids been shown to impair renal function?",
    "documents": [
      { "doc_id": "IM35_1", "text": "Alerts mention kidney injury risk with opioids.", "relevance": 1 },
      { "doc_id": "IM35_2", "text": "No significant renal impairment recorded in trials (p=0.80).", "relevance": 5 },
      { "doc_id": "IM35_3", "text": "Opioids may influence renal hemodynamics, but evidence is uncertain.", "relevance": 3 },
      { "doc_id": "IM35_4", "text": "Case reports note transient kidney injury.", "relevance": 1 },
      { "doc_id": "IM35_5", "text": "Some studies suggested mild kidney changes post-use.", "relevance": 1 },
      { "doc_id": "IM35_6", "text": "Renal markers remained stable across study groups.", "relevance": 4 },
      { "doc_id": "IM35_7", "text": "Systematic reviews found no conclusive opioid‑renal link.", "relevance": 5 }
    ]
  },
  {
    "query_id": "IM36",
    "query_type": "implicit_NOT",
    "query_text": "Do antihypertensives increase risk of sexual dysfunction?",
    "documents": [
      { "doc_id": "IM36_1", "text": "Safety alerts mention sexual dysfunction risk with antihypertensives.", "relevance": 1 },
      { "doc_id": "IM36_2", "text": "No significant sexual dysfunction signal in trials (p=0.83).", "relevance": 5 },
      { "doc_id": "IM36_3", "text": "They may affect libido, but evidence is inconclusive.", "relevance": 3 },
      { "doc_id": "IM36_4", "text": "Case studies describe dysfunction events.", "relevance": 1 },
      { "doc_id": "IM36_5", "text": "Some research hinted minor libido impact.", "relevance": 1 },
      { "doc_id": "IM36_6", "text": "Event rates remained similar between groups.", "relevance": 4 },
      { "doc_id": "IM36_7", "text": "Reviews found no definitive dysfunction link.", "relevance": 5 }
    ]
  }
]
